Delahunt, B., Egevad, L., Joseph, D., Attia, J., Denham, J. W., Srigley, J. R., Steigler, A., Murray, J. D., Atkinson, C., Matthews, J., Duchesne, G., Spry, N. A., Christie, D.. Lippincott Williams & Wilkins; 2015. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.

Delahunt, B., Steigler, A., Oldmeadow, C., Samaratunga, H., Spry, N. A., Thunders, M. C., Hondermarck, H., Denham, J. W., Atkinson, C., Christie, D., Duchesne, G., Egevad, L., Joseph, D., Kenwright, D. N., Matthews, J., Murray, J. D.. Elsevier; 2022. Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.